Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K H Hong

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
BJU International|September 8, 2011
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumoursNiall M Corcoran, Chris M Hovens, Matthew K H Hong, et al.
BJU International|January 20, 2012
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk diseaseNiall M Corcoran, Chris M Hovens, Charles Metcalfe, et al.
Pathology|March 13, 2012
Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysisMichael Kerger, Matthew K H Hong, John Pedersen, et al.
Pathology, Research and Practice|October 17, 2017
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk predictionMarcus C Hovens, Kevin Lo, Michael Kerger, et al.
Pathology|January 15, 2011
Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroupMatthew K H Hong, Benjamin Namdarian, Niall M Corcoran, et al.
Optics Letters|June 3, 2009
Highly stable ultrabroadband mid-IR optical parametric chirped-pulse amplifier optimized for superfluorescence suppressionJ Moses, S-W Huang, K-H Hong, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancerPatrick McCoy, Stefano Mangiola, Geoff Macintyre, et al.
Npj Quantum Materials|August 17, 2023
Dynamical ground state in the XY pyrochlore Yb<sub>2</sub>GaSbO<sub>7</sub>P M Sarte, K Cruz-Kan, B R Ortiz, et al.
Nature Communications|April 2, 2015
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancerMatthew K H Hong, Geoff Macintyre, David C Wedge, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
BJU International|September 8, 2011
Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumoursNiall M Corcoran, Chris M Hovens, Matthew K H Hong, et al.
BJU International|January 20, 2012
Positive surgical margins are a risk factor for significant biochemical recurrence only in intermediate-risk diseaseNiall M Corcoran, Chris M Hovens, Charles Metcalfe, et al.
Pathology|March 13, 2012
Microscopic assessment of fresh prostate tumour specimens yields significantly increased rates of correctly annotated samples for downstream analysisMichael Kerger, Matthew K H Hong, John Pedersen, et al.
Pathology, Research and Practice|October 17, 2017
3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk predictionMarcus C Hovens, Kevin Lo, Michael Kerger, et al.
Pathology|January 15, 2011
Prostate tumour volume is an independent predictor of early biochemical recurrence in a high risk radical prostatectomy subgroupMatthew K H Hong, Benjamin Namdarian, Niall M Corcoran, et al.
Optics Letters|June 3, 2009
Highly stable ultrabroadband mid-IR optical parametric chirped-pulse amplifier optimized for superfluorescence suppressionJ Moses, S-W Huang, K-H Hong, et al.
Prostate Cancer and Prostatic Diseases|June 10, 2021
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancerPatrick McCoy, Stefano Mangiola, Geoff Macintyre, et al.
Npj Quantum Materials|August 17, 2023
Dynamical ground state in the XY pyrochlore Yb<sub>2</sub>GaSbO<sub>7</sub>P M Sarte, K Cruz-Kan, B R Ortiz, et al.
Nature Communications|April 2, 2015
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancerMatthew K H Hong, Geoff Macintyre, David C Wedge, et al.
Pageof 8